| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |